Top Markets
Coin of the day
Tianjin Ringpu Bio-Technology Co.,Ltd. Tianjin Ringpu Bio-Technology Co.,Ltd.

Tianjin Ringpu Bio-Technology Co.,Ltd.

300119
주식 순위 #8815
Established in 1998 and based in Tianjin, China, Tianjin Ringpu Bio-Technology... Established in 1998 and based in Tianjin, China, Tianjin Ringpu Bio-Technology Co.,Ltd. focuses on the research, development, manufacturing, and commercialization of a broad spectrum of animal health solutions. Their product portfolio includes veterinary biologicals, pharmaceutical formulations, functional feed additives, and active pharmaceutical ingredients (APIs) for the Chinese market. The company provides a wide array of vaccines and medications for livestock, particularly poultry and swine. They also offer a comprehensive line of pet care products, such as inactivated rabies vaccines, recombinant canine-alpha interferon, inhalation anesthetics like isoflurane and sevoflurane for dogs and cats, cefquinoxime sulfate injections for bacterial infections, and cardiac treatments including napril chewable tablets. For waterfowl, their specialized offerings include live and inactivated duck tempusu vaccines, purified egg yolk antibodies for gosling plague and duck viral hepatitis, duck infectious serositis inactivated vaccines, as well as injectable and soluble powder treatments like florfenicol and kanamycin. Furthermore, Ringpu develops antifungal products featuring natural plant extracts, immune polysaccharides, probiotics (such as Clostridium butyricum and Lactobacillus plantarum), antibacterial peptides, enzyme preparations, and acidulants. Their disinfection and cleaning range comprises potassium hydrogen persulfate composite powder, various quaternary ammonium compounds (e.g., benzyl trimethyl ammonium chloride, deca methyl ammonium bromide), sodium dichloroisocyanurate, and iodine glycerin solutions. The company's API production includes crucial ingredients like tilmicosin, tilmicosin phosphate, monbutone, tidiroxine, florfenicol, vonimulin hydrochloride, and gamimycin.
주가
$2.51
마지막 동기화: 2026-08-28
시가총액
$1.17B
변동 (1일)
0.58%
변동 (1년)
-20.26%
국가
CN
거래 Tianjin Ringpu Bio-Technology Co.,Ltd. (300119)

카테고리

Tianjin Ringpu Bio-Technology Co.,Ltd. (300119)의 영업이익률
2026 기준 영업이익률 TTM: 0.00%
Tianjin Ringpu Bio-Technology Co.,Ltd.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 0.00%입니다. 2026년 말 기준 영업이익률은 0.00%였습니다.
Tianjin Ringpu Bio-Technology Co.,Ltd.의 영업이익률 기록 (2026 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 영업이익률
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.